Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
SAN RAMON, CA, UNITED STATES, September 24, 2024 /EINPresswire.com/ — Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation. The grant will support the development of Raydiant’s Lumerah™ technology, a non-invasive fetal pulse oximeter designed to enhance the detection of fetal distress during childbirth.
Lumerah™ measures fetal blood oxygen saturation to provide real-time insights during labor and delivery. The technology recently received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for expedited review. It has also gained Investigational Device Exemption (IDE) approval to begin an Early Feasibility Study (EFS) involving pregnant women in labor. The first participant was enrolled on May 15, 2024.
